| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/02/1997 | US5663335 Antiinflammatory agents; treatment of rheumatoid arthritis |
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663293 ICAM-related protein |
| 09/02/1997 | US5663292 Antagonist peptides; regulation of secretion of corticotropin |
| 09/02/1997 | US5663208 Pyruvic acid comppounds, antioxidants and fatty acids |
| 09/02/1997 | US5663174 Antiinflammatory agents, inhibitor of kinases, antiarthritic agents |
| 09/02/1997 | US5663157 For treating hyperproliferative diseases |
| 09/02/1997 | US5663151 Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
| 09/02/1997 | US5663142 For treating thrombosis, protein s deficiency, sepsis, inflammation and cancer |
| 08/28/1997 | WO1997031023A1 Peptide derivatives |
| 08/28/1997 | WO1997031010A1 Receptor protein designated 2f1 |
| 08/28/1997 | WO1997030999A1 Quinolones and their therapeutic use |
| 08/28/1997 | WO1997030699A2 Dosage form of ibuprofen |
| 08/28/1997 | WO1997030587A1 Dna vaccination for induction of suppressive t cell response |
| 08/28/1997 | DE19600939C1 Verfahren zur Trennung von IgG und IgA A method for separating IgG and IgA |
| 08/28/1997 | CA2242809A1 Peptide derivatives |
| 08/28/1997 | CA2242598A1 Quinolones and their therapeutic use |
| 08/27/1997 | EP0791592A2 Azetidines |
| 08/27/1997 | EP0791576A2 Leukotriene antagonistic benzoic acid derivatives |
| 08/27/1997 | EP0791011A2 Biologically active tgf-beta1 and tgf-beta2 peptides |
| 08/27/1997 | EP0790981A1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 08/27/1997 | EP0520005B1 Nitroxides for weight reduction |
| 08/27/1997 | EP0495781B1 Radiation synovectomy compositions |
| 08/27/1997 | CN1158121A Indolizine SPLA2 inhibitors |
| 08/27/1997 | CN1157815A 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 08/26/1997 | US5661187 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals |
| 08/26/1997 | US5661173 Administering an enzyme inhibitor treating diabetes |
| 08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
| 08/26/1997 | US5661159 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 08/26/1997 | US5661157 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 08/26/1997 | US5661138 (o-Acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines |
| 08/26/1997 | US5661020 Carboxylation; activation; covalently attaching to superoxide dismutase |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5660859 Gelation of low-molecular weight polymer in water using calcium acetate at room temperature; drug capsules; dental products; cosmetics; cariers |
| 08/26/1997 | CA2149245C Novel isoxazolines as antiinflammatory agents |
| 08/26/1997 | CA2140344C Antiinflammatory indolinyl n-hydroxyurea and n-hydroxamic acid derivatives |
| 08/21/1997 | WO1997031000A1 Quinolones and their therapeutic use |
| 08/21/1997 | WO1997030056A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997030055A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997030048A1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 08/21/1997 | WO1997030044A1 Quinazoline compounds |
| 08/21/1997 | WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies |
| 08/21/1997 | WO1997029780A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/21/1997 | WO1997029743A1 Il-8 receptor antagonists |
| 08/21/1997 | WO1997029635A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 08/21/1997 | CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
| 08/21/1997 | CA2246230A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/21/1997 | CA2245927A1 Il-8 receptor antagonists |
| 08/21/1997 | CA2241891A1 Quinolones and their therapeutic use |
| 08/21/1997 | CA2230639A1 Zwitterionic compositions and methods as biological response modifiers |
| 08/20/1997 | EP0790306A2 Tumor necrosis factor (tnf) inhibitor and use thereof |
| 08/20/1997 | EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them |
| 08/20/1997 | EP0790248A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists |
| 08/20/1997 | EP0790239A1 Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists |
| 08/20/1997 | EP0790059A1 Means for treating auto-immune diseases and method of treatment |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789713A1 Antibodies |
| 08/20/1997 | EP0789706A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
| 08/20/1997 | EP0789593A1 Yeast-based delivery vehicles |
| 08/20/1997 | EP0789571A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
| 08/20/1997 | EP0789569A2 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method |
| 08/20/1997 | EP0662954B1 Novel vitamin d analogues |
| 08/20/1997 | EP0654035B1 Phosphonoacetic esters and acids as anti-inflammatories |
| 08/20/1997 | EP0652892B1 Lactam dipeptides having hle inhibiting activity |
| 08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 08/20/1997 | EP0620737B1 Use of LACTOFERRIN iN the manufacture of a medicament for treating RHEUMATISM |
| 08/20/1997 | CN1157619A Pyrimido £5-4-d| pyrimidines, drugs containing these compounds, their use and process for preparing them |
| 08/20/1997 | CN1157617A Heterobicyclic derivatives |
| 08/20/1997 | CN1157615A Heterocyclic tachykinin receptor antagonists |
| 08/20/1997 | CN1157613A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/20/1997 | CN1157287A Arylalkyl diazinones |
| 08/20/1997 | CN1157136A Pharmaceutical agents for treatment of acute and chronic inflammatory diseases |
| 08/19/1997 | US5659018 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 08/19/1997 | US5658956 Bioadhesive-wound healing compositions and methods for preparing and using same |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658940 Inhibitors of tumor necrosis factor |
| 08/19/1997 | US5658932 Azacyclic compounds; cognitive function stimulants; alzheimer's disease |
| 08/19/1997 | US5658911 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 08/19/1997 | US5658903 Cytokine inhibitors |
| 08/19/1997 | US5658896 Water-soluble silicate polymer |
| 08/19/1997 | US5658885 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 08/19/1997 | US5658883 Biologically active TGF-β1 peptides |
| 08/19/1997 | US5658880 Prevent selectin binding; antiinflammatory, anticancer agents; aids therapy |
| 08/19/1997 | CA2007651C Anti-inflammatory 1-heteroaryloxindole-3-carboxamides |
| 08/19/1997 | CA1339299C Human manganese superoxide dismutase dna; its expression; method of recovering human manganese superoxide dismutase, human manganese superoxide dismutase analogs or human manganese superoxide dismutase mutants; uses;compositions; and methods of treatment |
| 08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/14/1997 | WO1997028828A1 Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 08/14/1997 | WO1997028797A1 Method of treatment and pharmaceutical composion |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/14/1997 | CA2245162A1 Method of treatment and pharmaceutical composition |
| 08/13/1997 | EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses |
| 08/13/1997 | EP0789021A1 Hydroxamic acid compounds as opioid kappa receptor agonists |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |